Novoheart Announces Appointment of New Chief Financial Officer

Novoheart Holdings Inc. announced the appointment of Joseph Leung (“Joseph”) as its new Chief Financial Officer (“CFO”) and Corporate Secretary.  Joseph will be replacing Dr. Camie Chan, who has been serving as the Company's interim CFO and Corporate Secretary.

Joseph has accumulated nearly two decades of experience in the field of financial management and accounting, specializing in mergers and acquisitions, compliance and risk management, and the development and monitoring of control systems.

Joseph most recently served as Head of Financial Planning and Control at Transport International Holdings Limited, a company publicly listed on the Hong Kong Stock Exchange, where he oversaw and managed the group’s corporate actions, fundraising activities, along with the formulation and monitoring of the budget process.  Prior to that, Joseph was the CFO and Company Secretary for another publicly listed company on the Hong Kong Stock Exchange.  Over the course of his career, Joseph participated in numerous capital market transactions including mergers and acquisitions, debt offerings as well as initial public offerings.  Joseph began his career articling with Ernst & Young Hong Kong before he moved on to enrich his expertise on capital market transactions in the Capital Market Services Group at PricewaterhouseCoopers (PwC) Hong Kong.  He is a Certified Public Accountant and holds a Bachelor of Arts (Honours) in Accounting from the University of British Columbia.

For detailed press release, please click here.

Subscribe To Our Newsletter

Fill out the following to subscribe and start receiving updates from us!